National School of Public Health, Ministry of Health, Lemfedel Cherkaoui Street, Madinat Al Irfane, 10000, Rabat, Morocco.
Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
BMC Public Health. 2018 Mar 15;18(1):358. doi: 10.1186/s12889-018-5260-9.
Cutaneous Leishmaniasis (CL) is a parasitic skin disease, linked to poverty, and belonging to the group of Neglected Tropical Diseases. Depending on the severity, the type of lesions or scars, and the context, CL can lead to self- and social stigma influencing the quality of life and psychological well-being of the patient. This dimension is, however, little documented for the most common, localized form of cutaneous leishmaniasis (LCL). We aimed to describe the current knowledge on the psychological burden and the stigma related to LCL.
The population of interest for this scoping review are patients or their relatives with localized LCL or related scars. We searched the electronic databases PubMed, Web of Knowledge, PsycINFO, POPLINE, Cochrane Library, Science Direct, Global Health, and LILACS, for articles written in Arabic, English, French, Dutch, Portuguese, or Spanish, and published until the end of August 2017.
From 2485 initial records, 15 papers met our inclusion criteria. Dermatology life quality index was the most frequent used scale to assess LCL psychological impact in quantitative studies. Six qualitative studies used individual interviews and/or focus groups discussions to explore the psychological and/or the social burden of this disease. Quantitative assessments using standard scales as well as qualitative research asserts that LCL is a source of psychological suffering, stigmatization, and decreased quality of life (QoL).
Most studies showed that LCL has a significant negative effect on the QoL and mental health. However, the fact that the psychosocial burden generated by LCL is time-dependent makes it hard to measure. We recommend to develop a more specific and validated assessment scale to appreciate the full burden of this disease and enhance comparability of findings.
皮肤利什曼病（CL）是一种寄生虫性皮肤病，与贫困有关，属于被忽视的热带病之一。根据严重程度、病变或疤痕类型以及具体情况，CL 可能导致患者产生自我和社会耻辱感，影响其生活质量和心理健康。然而，对于最常见的局限性皮肤利什曼病（LCL），这一方面的文献却很少。我们旨在描述与 LCL 相关的心理负担和耻辱感的现有知识。
本范围综述的目标人群是患有局限性 LCL 或相关疤痕的患者或其亲属。我们检索了电子数据库 PubMed、Web of Knowledge、PsycINFO、POPLINE、Cochrane Library、Science Direct、Global Health 和 LILACS，以获取截至 2017 年 8 月底发表的阿拉伯语、英语、法语、荷兰语、葡萄牙语或西班牙语的文章。
从 2485 篇初始记录中，有 15 篇符合我们的纳入标准。皮肤病生活质量指数是定量研究中评估 LCL 心理影响最常用的量表。6 项定性研究使用个人访谈和/或焦点小组讨论来探讨该疾病的心理和/或社会负担。使用标准量表进行定量评估以及定性研究均表明，LCL 会导致心理痛苦、耻辱感和生活质量（QoL）下降。
大多数研究表明，LCL 对 QoL 和心理健康有显著的负面影响。然而，LCL 所产生的心理社会负担是时变的，这使得很难进行衡量。我们建议开发更具体和经过验证的评估量表，以全面评估该疾病的负担，并增强研究结果的可比性。
